New Concepts and Emerging Therapies in Metabolic Disorders and Vascular Disease (METAB14)

Organization: UC Davis Health System, Office of CME and Division of Cardiovascular Medicine

Venue: Marriott Monterey

Location: Monterey, California, United States

Event Date/Time: Oct 05, 2013 End Date/Time: Oct 06, 2013
Report as Spam

Description

At the end of the activity, participants should be able to: • Explain the pathophysiology of hypertension • Use rationale therapies for the treatment of arrhythmias • Judge the results of imaging studies of cardiovascular pathology • Summarize how to work up the “difficult to treat” hypertensive • Explain new therapies and choose the appropriate work up for patients with diabetic dyslipidemia • Discuss how diastolic dysfunction causes heart failure • Identify appropriate implementation of heart disease preventive therapies in women • Compare the pathophysiology of hypertension and what the effect of antihypertensive therapy has on cognitive function and kidney failure • Explain new interventions in patients with congenital heart disease • Determine workup for causes of secondary hypertension

Venue

350 Calle Principal
Monterey
California
United States
MORE INFO ON THIS VENUE

Organizations

UC Davis Health System, Office of CME and Division of Cardiovascular Medicine
3560 Business Dr. #130
Sacarmento
California
95820
United States
UC Davis Health System, Office of CME and Division of Cardiovascular Medicine
3560 Business Dr. #130
Sacarmento
California
95820
United States

Conference Speakers

COURSE CHAIR John C. Rutledge, M.D. Professor, Division of Cardiovascular Medicine Department of Internal Medicine, Co-Vice Chair for Research Richard A. and Nora Eccles Harrison Endowed Chair in Diabetes Research University of California, Davis Health System

Additional Information

This conference is designed to change physician competence in managing patients with complex metabolic disease and patient management problems by selecting evidencebased therapeutic targets and regimens. We will use guidelines based on cardiovascular risk classification and comorbidities for lipid management, identifying components of the clinical characteristics of the metabolic syndrome in order to modify risk, using a state-of-the-art blueprint to manage the obesity epidemic, and associating insulin resistance with an increased risk of hypertension and coronary heart disease and dysrhythmias. This year’s conference will specifically address these identified educational needs and provide practitioners with evidence based guidelines from the National Institutes of Health and Joint Commission as well as state-of-the art tools to provide improved treatment options for their patients.

Methods of educational delivery will include: • Case studies of commonly seen clinical problems • Panel discussion including questions and answers • Audience response pre and post questioning

Exhibits included

Exhibitors will have a 6 foot table to display their products.  Call 916-734-1388 for cost.